DANBURY, Conn. (AP) — DANBURY, Conn. (AP) — MannKind Corp. (MNKD) on Thursday reported a loss of $17.9 million in its fourth quarter.
On a per-share basis, the Danbury, Connecticut-based company said it had a loss of 7 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.
The biopharmaceutical company posted revenue of $36.1 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $36.2 million.
For the year, the company reported that its loss widened to $87.4 million, or 34 cents per share. Revenue was reported as $99.8 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNKD at https://www.zacks.com/ap/MNKD
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.